Form 4: Genasys Inc. Director Mark Culhane Increases Stake in Company

Director Mark Culhane reported purchasing a significant number of Genasys Inc. shares over several days in August 2024.

Summary

• Mark Culhane, a director of Genasys Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On August 15, 2024, Culhane purchased 17,587 shares of common stock at a weighted average price of $2.65.
• The purchases on August 15th were made in multiple transactions at prices ranging from $2.62 to $2.65.
• On August 16, 2024, he acquired an additional 31,800 shares at a weighted average price of $2.67.
• The purchases on August 16th were made in multiple transactions at prices ranging from $2.65 to $2.70.
• On August 19, 2024, Culhane purchased 613 shares at $2.7.
• Following these transactions, Culhane directly owns 70,000 shares of Genasys Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a positive sign, but it's a routine transaction.

Positives

• A director's increased investment in the company may signal confidence in its future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.

Stakeholder Impact

• Shareholders may view the director's stock purchases as a positive signal.

Key Dates